Home
About
FAQ
History (19)
Predicting Mortality in African Americans With Type 2 Diabetes Mellitus: Soluble Urokinase Plasminogen Activator Receptor, Coronary Artery Calcium, and High-Sensitivity C-Reactive Protein.
Role of a proline insertion in the insulin promoter factor 1 (IPF1) gene in African Americans with type 2 diabetes.
Unexpected interaction of methylphenidate (Ritalin) with anaesthetic agents.
Treatment of Molluscum Contagiosum with Imiquimod in the United States: A Retrospective Cross-Sectional Study.
Clobetasol propionate for psoriasis: are ointments really more potent?
See All 19 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Clobetasol propionate for psoriasis: are ointments really more potent?
Warino L, Balkrishnan R, Feldman SR. Clobetasol propionate for psoriasis: are ointments really more potent? J Drugs Dermatol. 2006 Jun; 5(6):527-32.
View in:
PubMed
subject areas
Administration, Topical
Adult
Clobetasol
Dermatologic Agents
Double-Blind Method
Emollients
Humans
Ointments
Patient Satisfaction
Psoriasis
Randomized Controlled Trials as Topic
Severity of Illness Index
Treatment Outcome
authors with profiles
Steven R. Feldman MD, PhD